GW Pharma Wants Out Of Canopy's CBD Patent Dispute
GW Pharmaceuticals has asked a Texas federal court to toss a patent suit brought by Canadian cannabis company Canopy Growth over the flagship CBD drug Epidiolex, arguing that the court has...To view the full article, register now.
Already a subscriber? Click here to view full article